Despite the discovery of the cd T-cell receptor (TCR) over 30 years ago, the exact role of cd T cells in infectious disease, cancer and transplant immunology remains unclear. Nevertheless, cd T cells are frequently implicated in both antimicrobial and anti-tumor immunity. 1 cd T cells are formed of innate-like and adaptive populations, that recognise target cells in a major histocompatibility complex (MHC)-independent fashion, consistent with a lack of surface CD4/ CD8ab co-receptor expression. Studies in mice have highlighted 'innate-like' cd T cells subsets emerging early in thymic development, bearing semi-invariant TCRs, 1,2 suggestive of a limited range of self-ligands. Recent studies in humans have also identified that a major human cd T-cell population, constituting the largest subset of cd T cells at tissue locations, follow an adaptive immunobiology. [3] [4] [5] In this Special Feature of Clinical & Translational Immunology, we have invited experts in cd T-cell biology to provide an overview of the emerging roles of this often overlooked and unique population of T cells in health and disease ( Figure 1 ).
Siegers et al. 6 provide a memorial article in commemoration of the late Professor Paul Fisch . Paul was a pioneer of cd T-cell research where he made a profound contribution to our understanding of cd T cells. Paul was one of the first to describe the unique responses of cd T cells in infection and cancer, and provided evidence suggesting cd T-cell recognition events were independent of MHC molecules.
Dantzler et al. 7 provide an overview of cd T-cell responses in infectious diseases of global health importance, such as tuberculosis, malaria and influenza. This review highlights several recent studies investigating cd T-cell responses to vaccines targeting these infections.
Juno et al. 8 highlight the impact of acute, chronic untreated and treated HIV infection on peripheral cd T-cell subsets and discuss new insight into the potential for harnessing cd T cells as components of an anti-HIV immunotherapy.
Raverdeau et al. 9 highlight the exciting new avenues for harnessing cd T cells in anti-cancer immunotherapies but also underscore evidence for the pro-tumor properties of cd T cells.
Sullivan et al. 10 review the evidence for cd T cells in solid organ and haematopoietic stem cell transplantation. The authors focus on their potential roles in allograft acceptance and rejection, as well as their impact on transplantassociated infection and post-transplant malignancy.
Together, this collection of reviews highlights current paradigms in cd T-cell biology in health and disease. Each article then places cd T cells in scenarios of infection and immunityalbeit 'good, the bad and sometimes confusing'further emphasising the critical importance of developing a better understanding of this unconventional Tcell population. 
